Las Vegas Vioxx Attorney

Vioxx

Glen J. Lerner & Associates is currently reviewing claims related to the drug Vioxx, which has been voluntarily recalled by Merck & Co., Inc. from the U.S. and worldwide market due to safety concerns of an increased risk of cardiovascular events (including heart attack and stroke) in patients on Vioxx.

Vioxx is a prescription COX-2 selective, non-steroidal anti-inflammatory drug (NSAID) that was approved by FDA in May 1999 for the relief of the signs and symptoms of osteoarthritis, for the management of acute pain in adults, and for the treatment of menstrual symptoms, and was later approved for the relief of the signs and symptoms of rheumatoid arthritis in adults and children.

About two million people worldwide were taking Vioxx at the time of the recall, and a total of 84 million have taken it since it came on the market in 1999. Potential Vioxx, Celebrex or Bextra Claims

Because the drugs Celebrex and Bextra are in the same pharmaceutical class as Vioxx, we are reviewing potential claims related to the consumption of these drugs.

Injuries or death claims involving Vioxx will likely be based on the following criteria:
Documented use of Vioxx, Celebrex or Bextra for any length of time and Significant adverse event(s) after taking the medication, including heart attack, transient ischemic attack (TIA), stroke or death.

If you or a loved one has been injured as a result of a being prescribed the drug Vioxx Click Here so that
Glen J. Lerner can personally review the merits of your claim today.